Non-pharmacological Approaches to the Treatment of Maladaptive Aggression in Children and Adolescents

Non-pharmacological Approaches to the Treatment of Maladaptive Aggression in Children and Adolescents

US Psychiatry 2007;1:32-4

dots

National survey data indicate that the prevalence of aggressive conductproblems in young children is 10–25%.1 Early-onset conduct problems,including oppositional defiant, aggressive, and non-compliant behaviors,have been shown to predict poor academic and social functioning, aswell as serious health and behavioral issues in adolescence, such as drugabuse, school drop-out, depression, juvenile delinquency, and violence.1–4Early intervention can considerably benefit patients, families, andcommunities, as conduct problems in young children are more malleableprior to the age of eight years.5

A substantial proportion of psychiatric and mental health services is devoted to the treatment of severely aggressive, disruptive, and defiant children and adolescents. Aggressive behavior, which is usually thought of as a physical behavior with the potential to harm or damage a living being or inanimate object,6is highly distressing to witness, poses a significant threat to self and others, and is a leading cause of psychiatric hospitalization.7–9 Despite a growing awareness that maladaptive aggression can be a debilitating psychiatric symptom,10,11 developing and evaluating treatments for aggression has been difficult, as aggressive behaviors occur in a variety of environmental and psychiatric contexts.12

While most aggressive youth are diagnosed with a disruptive behavior disorder—conduct disorder (CD) or oppositional defiant disorder (ODD)—aggression also occurs with many other sub-threshold or primary psychiatric conditions, such as attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), and mood and anxiety disorders.13,14 Moreover, methodological problems, such as reliably defining and assessing aggression and maintaining pediatric subjects in studies with long baseline periods,6 have restricted the scientific study of aggression. As a result of limited research in this area, interventions for aggressive youth are largely based on heuristic clinical practices, the adult literature, and case reports.12 Efforts to reduce the costs of mental health treatment by rationing psychosocial approaches and limiting hospitalization have further complicated treatments for aggression, leading standard clinical practices to coincide with increasing financial and social pressures rather than rigorous scientific data.12 Children and adolescents with maladaptive aggression often receive a combination of medication and psychotherapy, depending on diagnosis, age, and symptom severity.11,12 Although a variety of medications— including atypical antipsychotics, mood stabilizers, and stimulants—show substantial efficacy in reducing aggression associated with different primary conditions,12,15–21 these pharmacological approaches are generally adjunctive to comprehensive psychosocial, community, and psychoeducational interventions, as the underlying neurobiological mechanisms involved in aggression responding remain largely unknown.22 Moreover, recent increases in prescribing to pediatric populations, often on an off-label basis,23,24 have led parents, educators, and service providers to increasingly explore non-medication treatment options. This article therefore reviews current psychosocial treatments for managing maladaptive aggression in children and adolescents.

Multimodal Treatment
To date, multimodal treatment approaches, which involve parent training, structural family therapies, and child skill-building treatments, have demonstrated the greatest efficacy in managing persistent aggressive behaviors in children and adolescents. These multifocused approaches show a medium to large effect (ranging from 0.4 to 0.9) on conduct problems and aggression in at-risk youth, and demonstrate sustained effects after treatment completion.22,25–29

To view full article click here

References:
  1. Loeber R, Farrington DP (eds), Child Delinquents: Development,Intervention, and Service Needs, Thousand Oaks, CA: Sage;2001:25–46.
  2. Webster-Stratton C, Hammond M, Clin Child Fam Psychol Rev,1998;1:101–24.
  3. Campbell M, Malone RP, Hosp Community Psychiatry,1991;42:374–9.
  4. Egeland B, Kalkoske M, Gottesman N, Erickson MF, J Child PsycholPsychiatry, 1990;31:891–909.
  5. Eron LD, Bulletin for the International Society for Research onAggression, 1990;12:5–9.
  6. Volavka J, J Neuropsychiatry Clin Neurosci, 1999;11:307–14.
  7. Gutterman EM, J Am Acad Child Adolesc Psychiatry,1998;37:1030–37, discussion 1038–40.
  8. McClellan J,Werry J, J Am Acad Child Adolesc Psychiatry,1997;36:157S–76S.
  9. Quinn KP, Newman DL, Cumblad C, Journal of Emotional andBehavioral Disorders, 1995;3:166–73.
  10. Connor DF, Glatt SJ, Lopez ID, et al., J Am Acad Child AdolescPsychiatry, 2002;41:253–61.
  11. Pappadopulos E, Macintyre Ii JC, Crismon ML, et al., J Am AcadChild Adolesc Psychiatry, 2003;42:145–61.
  12. Schur SB, Sikich L, Findling RL, et al., J Am Acad Child AdolescPsychiatry, 2003;42:132–44.
  13. Hinshaw SP, J Consult Clin Psychol, 1992;60:893–903.
  14. Walker JL, Lahey BB, Russo MF, et al., J Am Acad Child AdolescPsychiatry, 1991;30:187–91.
  15. Turgay A, Binder C, Snyder R, Fisman S, Pediatrics, 2002;110:e34.
  16. Croonenberghs J, Fegert JM, Findling RL, et al., J Am Acad ChildAdolesc Psychiatry, 2005;44:64–72.
  17. Findling RL,J Clin Psychiatry, 2004;65(Suppl. 6):3–4.
  18. Greenhill LL, Solomon M, Pleak R, Ambrosini P, J Clin Psychiatry,1985;46:20–25.
  19. Campbell M, Adams PB, Small AM, et al., J Am Acad Child AdolescPsychiatry, 1995;34:445–53.
  20. Malone RP, Delaney MA, Luebbert JF, et al., Arch Gen Psychiatry,2000;57:649–54.
  21. Connor DF, Glatt SJ, Lopez ID, et al., J Am Acad Child AdolescPsychiatry, 2002;41:253–61.
  22. Connor DF, Carlson GA, Chang KD, et al., J Clin Psychiatry,2006;67:808–20.
  23. Olfson M, Blanco C, Liu L, et al., Arch Gen Psychiatry,2006;63:679–85.
  24. Cooper WO, Hickson GB, Fuchs C, et al., Arch Pediatr Adolesc Med,2004;158:753–9.
  25. Webster-Stratton C, Reid MJ, Hammond M, J Clin Child AdolescPsychol, 2004;33:105–24.
  26. Webster-Stratton C, Taylor T, Prev Sci, 2001;2:165–92.
  27. Gresham FM, MacMillan DL, J Autism Dev Disord, 1998;28:5–13.
  28. Kazdin AE, Esveldt-Dawson K, French NH, Unis AS, J Consult ClinPsychol, 1987;55:76–85.
  29. Farmer EM, Dorsey S, Mustillo SA,Child Adolesc Psychiatr Clin N Am,2004;13:857–84, vi.
  30. Tremblay RE, Pagani-Kurtz L, Masse LC, et al., J Consult ClinPsychol, 1995;63:560–68.
  31. Webster-Stratton C, J Consult Clin Psychol, 1994;62:583–93.
  32. Webster-Stratton C, J Consult Clin Psychol, 1989;57:550–53.
  33. Kazdin AE, Mazurick JL, J Consult Clin Psychol, 1994;62:1069–74.
  34. Lochman JE,Wells KC, J Consult Clin Psychol, 2004;72:571–8.
  35. Henggeler SW, Edwards J, Borduin CM, J Abnorm Child Psychol,1987;15:199–209.
  36. Kashani JH, Suarez L, Jones MR, Reid JC, J Affect Disord,1999;52:269–74.
  37. Henggeler SW, Rowland MD, Pickrel SG, et al., J Clin Child Psychol,1997;26:226–33.
  38. Henggeler SW, Cunningham PB, Pickrel SG, et al., J Adolesc,1996;19:47–61.
  39. Burns GL, Patterson DR, J Clin Child Psychol, 2000;29:569–77.
  40. Alexander JF, Parsons BV, Functional Family Therapy: Principles andProcedures, Carmel, CA: Brooks/Cole, 1982.
  41. Sexton TL, Alexander JF, Functional Family Therapy: Principles ofClinical Intervention, Assessment, and Implementation, Henderson,NV: RCH Enterprises, 1999.
  42. Sexton TL, Alexander JF, Functional family therapy,Washington,DC: U.S. Department of Justice, Office of Justice Programs, Officeof Juvenile Justice and Delinquency Prevention, 2000.
  43. Szapocznik J, Williams RA, Clin Child Fam Psychol Rev,2000;3:117–34.
  44. Reid W, Can J Psychiatry, 1981;26:421–5.
  45. Dishion TJ, Loeber R, Am J Drug Alcohol Abuse, 1985;11:11–25.
  46. Brestan EV, Eyberg SM, J Clin Child Psychol, 1998;27:180–89.
  47. Taylor TK, Biglan A, Clin Child Fam Psychol Rev, 1998;1:41–60.
  48. Barkley RA, Koplowitz S, Anderson T, McMurray MB, J IntNeuropsychol Soc, 1997;3:359–69.
  49. Kazdin AE, Annu Rev Psychol, 2003;54:253–76.
  50. Crick NR, Dodge KA, Psychological Bulletin, 1994;115:74–101.
  51. Kazdin AE, J Am Acad Child Adolesc Psychiatry, 1997;36:1349–56.
  52. Kazdin AE, Child Adolesc Psychiatr Clin N Am, 2000;9:841–58.
  53. Kendall PC, Morris RJ, J Consult Clin Psychol, 1991;59:777–84.
  54. Durlak JA, Fuhrman T, Lampman C, Psychol Bull,1991;110:204–14.
  55. Dodge KA, Coie JD, Pettit GS, Price JM, Child Dev,1990;61:1289–1309.
  56. Lochman JE,Wayland KK, J Am Acad Child Adolesc Psychiatry,1994;33:1026–35.
  57. Jensen PS, Bhatara VS, Vitiello B, et al., J Am Acad Child AdolescPsychiatry, 1999;38:557–65.
  58. Pappadopulos E,Woolston S, Chait A, et al., J Can Acad ChildAdolesc Psychiatry, 2006;15:27–39.
  59. Connor DF, Steingard RJ, Cunningham JA, et al., Am JOrthopsychiatry, 2004;74:129–36.
  60. Steiner H, Saxena K, Chang K, CNS Spectr, 2003;8:298–308.
  61. Vitiello B, Behar D, Hunt J, et al., J Neuropsychiatry Clin Neurosci,1990;2:189–92.
  62. Webster-Stratton C, Dahl RW, Advanced Abnormal ChildPsychology, 1st edn, Hillsdale, NJ: Lawrence Erlbaum Associates;1995:333–52.
  63. Zayas LH, Fam Syst Med, 12:315–25.

Copyright® 2012 Touch Group PLC. All rights reserved.
Touch Neurology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.